US · Healthcare

Doseology Sciences Inc. (DOSEF)

Biotechnology

Doseology Sciences Inc. (DOSEF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DOSEF

P/E ratio

25.00

Doseology Sciences Inc. (DOSEF) — FAQ

What is DOSEF's P/E ratio?

The price-to-earnings (P/E) ratio for Doseology Sciences Inc. (DOSEF) is 25.00 (data as of 2026-05-23).

Does Doseology Sciences Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Doseology Sciences Inc. (DOSEF). Check the MyAverix Finance app for the latest dividend data.

What sector is Doseology Sciences Inc. in?

Doseology Sciences Inc. (DOSEF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DOSEF listed on?

DOSEF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)